Dr. Superko is an internationally recognized expert in preventive cardiology trained at the State University of New York and the University of California-Davis. He conducted multiple NIH funded clinical trials as Director of the Stanford University Lipid Research Clinic and Laboratory (LRC-CPPT) from 1981 to 1990, Director of the University of California, Berkeley, Cholesterol Research Center at the Lawrence Berkeley National Laboratory from 1990 to 2000, Director of Research at Berkeley HeartLab from 2000 to 2004, and Chairman of Molecular and Genetic Cardiology at the Fuqua Heart Center and Saint Joseph’s Hospital in Atlanta, Georgia from 2004 to 2009. He was Chief Medical Officer and Vice President at Celera Corporation (a gene discovery company) and affiliated with Quest Diagnostics from 2009-2014. He is affiliated with the Mercer University School of Pharmaceutical Sciences in Atlanta, Georgia and currently Chairman of the non-profit Cholesterol, Genetics, and Heart Disease Institute.
Dr. Superko has participated in many CME programs and committees as a Fellow of the American College of Cardiology and the American Heart Association. He was Director of the American Heart Association Lipid Disorders Training Center in California and Chairman of several National CME programs. He has received many awards and honors, most recently the Larry King Cardiac Foundation Physician Laureate award for life-time efforts in preventive cardiology.
He is on the editorial board of five medical journals and a reviewer for twenty-nine. He has published 125 manuscripts, 19 text book chapters, one public book and 127 abstract presentations.
His current interests involve individual response to lifestyle and pharmaceutical induced change in factors linked to coronary heart disease. This includes the use of genetic tests to identify patient subgroups that respond differently to specific therapeutic interventions that result in a differential effect on clinical outcomes.